The invention discloses a liver / mitochondria dual-targeting
carboxylesterase fluorescent probe as well as a preparation method and application thereof, and belongs to the technical field of medicines. The probe is a compound LDM-CA, has the liver and mitochondria dual-targeting characteristic, and shows
high selectivity, sensitivity and
strong binding affinity to CEs. In-vitro
cell experiments show that the LDM-CA has excellent
mitochondrial targeting ability in the HCC cells and
specific fluorescence opening response to CEs in the cells, and can clearly distinguish the HCC cells from normal liver cells or non-
liver cancer cells. In-vivo imaging of a mouse model shows that no matter in-tumor injection or intravenous injection, the LDM-CA can effectively visualize the HCC tumor and draw the edge of the tumor, has the prospect of serving as a powerful molecular tool for
early HCC diagnosis and image-guided
surgery, and also provides a valuable means for studying the action of mitochondrial CEs activity in HCC
pathogenesis at the subcellular level.